Title: Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition.
Journal: Journal of medicinal chemistry 20120614
29385-43-1
1680-44-0
51719-84-7
1803587-68-9
1803601-79-7
1803570-12-8
1205750-98-6 | tert-butyl 3-(4-aminobutyl)azetidine-1-carboxylate | AA01CA15 | MFCD14582362
1365939-28-1 | 5-methoxy-1-methyl-1H-pyrazole-4-carbaldehyde | AA01CA7Q | MFCD21601621
1206723-31-0 | 2-chloro-5-(1-ethoxyethenyl)pyrazine | AA01CABX | MFCD28658168
1346617-22-8 | (R)-3-(4-Chlorophenyl)-4-hydroxybutyric Acid Sodium Salt | AA01CB32
86784-80-7 | Corticotropin-releasing factor (human) | AA01CB66 | MFCD00213806
942193-17-1 | (R)-De(carboxymethoxy) Cetirizine Acetic Acid | AA01CB9C
1839099-22-7 | (R)-N-Desacryloyl N-Propionyl Ibrutinib | AA01CBCM | MFCD28969691
1309457-19-9 | 2-Hydroxyalmotriptan | AA01CBGG
956026-24-7 | 1-(tert-Butyl)-3-(2,3-dimethylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | AA01CBJF | MFCD18382153
1798014-64-8 | 5-(Hydroxymethyl)-3-[2-(2-methoxyphenoxy)ethyl]-2-oxazolidinone | AA01CBN1 | MFCD31568265